New study pits dronedarone against standard drugs for AF control
NCT ID NCT07270848
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of medicine for atrial fibrillation (AF), a condition causing irregular heartbeat. About 1,900 adults diagnosed with AF in the past year will be randomly assigned to take either dronedarone or a standard Class Ic drug (like flecainide). Researchers will track which medicine better prevents AF from returning, monitor side effects, and measure changes in quality of life over at least 12 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ewha Womans University Seoul Hospital
Seoul, 07804, South Korea
-
Hanyang University Guri Hospital
Guri-si, 11923, South Korea
-
Inha University Hospital
Incheon, Incheon, 22332, South Korea
-
Inje University Ilsan Paik Hospital
Goyang, 10380, South Korea
-
Jeju National University Hospital
Jeju City, 63241, South Korea
-
Korea University Anam Hospital
Seoul, 02841, South Korea
-
Korea University Ansan Hospital
Ansan, 15355, South Korea
-
Korea University Guro Hospital
Seoul, 08308, South Korea
-
Kosin University Gospel Hospital
Busan, 49267, South Korea
-
Myongji Hospital
Goyang-si, 10475, South Korea
-
NHIS Ilsan Hospital
Goyang-si, 10444, South Korea
-
Sejong Chungnam National University Hospital
Sejong, 30099, South Korea
-
Severance Hospital
Seoul, 03722, South Korea
-
Soonchunhyang University Bucheon Hospital
Bucheon-si, 14584, South Korea
-
Soonchunhyang University Cheonan Hospital
Cheonan, 31151, South Korea
-
Wonju Severance Christian Hospital
Wŏnju, 26426, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone alert replace daily blood thinners for AF?
- Blood fat clues could flag hidden heart rhythm risk
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Smartphone light sensor may spot when an irregular heartbeat fixes itself
- Can a Wrist-Worn sensor outsmart atrial fibrillation?